Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) announced that the European Medicines Agency's Committee for Medicinal Products for Human Use adopted a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE